CINECA IRIS Institutional Research Information System

UGOLINI, CLARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.323
EU - Europa 4.372
AS - Asia 1.076
AF - Africa 232
SA - Sud America 22
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.196
IT - Italia 1.850
SE - Svezia 978
DE - Germania 578
CN - Cina 444
SG - Singapore 293
BG - Bulgaria 275
GB - Regno Unito 240
AT - Austria 162
CI - Costa d'Avorio 147
CA - Canada 127
TR - Turchia 107
VN - Vietnam 93
FI - Finlandia 80
SN - Senegal 66
IN - India 46
HK - Hong Kong 41
RU - Federazione Russa 40
UA - Ucraina 39
BE - Belgio 25
CH - Svizzera 23
FR - Francia 23
BR - Brasile 17
NG - Nigeria 17
IR - Iran 14
PL - Polonia 14
CZ - Repubblica Ceca 10
JP - Giappone 8
KR - Corea 8
JO - Giordania 7
NL - Olanda 7
RO - Romania 5
AU - Australia 4
ES - Italia 4
TW - Taiwan 4
CL - Cile 3
HU - Ungheria 3
DK - Danimarca 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
MY - Malesia 2
RS - Serbia 2
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.030
Salva come PNG Salva come JPEG
Città #
Fairfield 778
Chandler 632
Woodbridge 595
Ashburn 460
Houston 438
Ann Arbor 429
Seattle 319
Milan 297
Sofia 275
Wilmington 269
Cambridge 248
New York 218
Beijing 188
Boardman 164
Princeton 150
Vienna 150
Abidjan 147
Lawrence 131
Ottawa 115
Medford 109
Pisa 109
Florence 107
Izmir 98
Serra 96
Singapore 96
London 88
Rome 73
Nanjing 70
Dakar 66
Des Moines 66
Bremen 55
San Diego 51
Frankfurt am Main 47
Jacksonville 47
Naples 44
Dearborn 43
Hong Kong 36
Dallas 35
Boulder 32
Los Angeles 31
Ogden 30
Dong Ket 28
Nanchang 28
Bologna 26
Vicopisano 25
Brussels 23
Lancaster 21
Munich 21
Bern 19
Redmond 18
Lagos 17
Genoa 16
Norwalk 16
Redwood City 16
Changsha 15
Washington 15
Kunming 13
Turin 13
Falls Church 12
Jaboatão 11
Pune 11
Verona 11
Barberino di Mugello 10
Hebei 10
Hyderabad 10
Jüchen 10
Trieste 10
Indiana 9
Palermo 9
Parma 9
Seacroft 9
Tianjin 9
Warsaw 9
Hefei 8
Kent 8
Lucca 8
Philadelphia 8
San Francisco 8
Brno 7
Cuneo 7
Fremont 7
Jiaxing 7
Marseille 7
Nürnberg 7
Salerno 7
Shanghai 7
Shenyang 7
Stockholm 7
Zhengzhou 7
Hangzhou 6
Helsinki 6
La Spezia 6
Lappeenranta 6
Messina 6
Phoenix 6
San Giuliano Terme 6
Santa Clara 6
Tappahannock 6
Trevignano 6
Venice 6
Totale 8.094
Salva come PNG Salva come JPEG
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 825
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 258
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 167
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 162
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 161
null 160
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 145
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 145
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 144
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 141
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 135
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 133
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 133
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 123
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 120
miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features’ compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas 120
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 120
Interest of sentinel node biopsy in apparently intrathyroidal medullary thyroid cancer: a pilot study. 116
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 116
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 115
HISTIDINE-RICH GLYCOPROTEIN AND HUMAN SKELETAL MUSCLE: POSSIBLE INVOLVEMENT IN MUSCLE CONTRACTION 115
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 114
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 113
A microRNA signature for the differential diagnosis of salivary gland tumors 113
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 111
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 110
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 110
Chronic lithium re-sizes motor neurons and induces neuronogenesis in the spinal cord of a mouse model of amyotrophic lateral sclerosis 108
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 107
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 107
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 107
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma 107
EVIDENCE OF A LOW PREVALENCE OF RAS MUTATIONS IN A LARGE MEDULLARY THYROID CANCER SERIES 106
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 106
Role of YAP-1 in Thyroid Tumor Progression and Outcome 106
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma 105
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 105
Digital Gene Expression Analysis on Cytology Smears Can Rule Out Malignancy in Follicular-Patterned Thyroid Tumors 105
Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer 104
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 104
Differences in miRNA expression profiles between wild-type and mutated NIFTPs 103
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 103
Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. 102
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 102
Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study 101
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma 101
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 100
Lower levels of TSH are associated to a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role 98
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 98
Synchronous Squamous Cell Carcinoma and Papillary Thyroid Carcinoma Arising from the Thyroglossal Duct Remnant: case report and a review of the literature. 98
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. 97
A dual mechanism of activation of the sonic hedgehog pathway in anaplastic thyroid cancer: Crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma 96
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. 95
Identification of targets of twist1 transcription factor in thyroid cancer cells 95
Mast cells have a protumorigenic role in human thyroid cancer 93
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 93
Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications 92
Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers 92
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 92
HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer 92
Effects of proton pump inhibitors on healing of gastric ulcerations induced by a continued non steroidal anti-inflammatory drug (NSAID) treatment 91
Functional Characterization of the Novel T599I-VKSRdel BRAF Mutation in a Follicular Variant Papillary Thyroid Carcinoma 90
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 88
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 88
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior 87
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 87
null 86
A retrospective analysis of her-2 hyperexpression in gastric and gastroesophageal junction (gej). 86
Human α-L-fucosidase-1 attenuates the invasive properties of thyroid cancer 85
Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study 84
Correlation Between The Presence Of Macrophages And Braf V600e Mutation In Different Variants Of Well Differentiated Papillary Thyroid Cancer 84
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion 83
Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications. 82
Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens 81
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like 80
Significato prognostico della mutazione di BRAF in pazienti affetti da carcinoma papillare della tiroide con follow-up di 20 anni. 79
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 79
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 78
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways 77
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 76
L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients 76
Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules 74
Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene 73
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation 73
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 72
Effects of proton pump inhibitors on healing of NSAID-induced gastric ulcerations in the presence of a continued NSAID treatment: characterization of molecular mechanisms 70
Short term follow-up outcome of stage I thyroid cancer patients is worst when BRAFV600E mutation is present in the primary tumor. 70
null 69
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 69
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 69
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study. 66
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 66
COVID-19 autopsy cases: detection of virus in endocrine tissues 65
Fenotipo misto MEN2A/MEN2B da nuova mutazione germinale di RET: prima descrizione clinico-genetica e iconografia 63
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 62
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 61
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 60
First report of benign track seeding after robot-assisted transaxillary thyroid surgery 59
Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations 59
Primary perivascular epithelioid cell tumor (pecoma) of the ovary: A case report and review of the literature 58
Totale 10.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.493 0 0 0 137 180 221 200 152 178 167 207 51
2020/20211.059 85 64 73 51 64 60 192 66 132 74 67 131
2021/20221.597 47 38 56 108 298 235 62 74 75 72 122 410
2022/20232.654 330 408 187 195 250 291 59 194 446 46 196 52
2023/20242.013 186 168 189 205 249 286 158 87 77 89 127 192
2024/2025500 135 229 96 40 0 0 0 0 0 0 0 0
Totale 12.341